甲骨文预计将公布更高的第一季度收益；在收益电话会议之前，这些最准确的分析师已修订了预测
Oracle Corporation is set to report Q1 earnings on Sept. 9, with expectations of $1.48 per share, up from $1.39 last year, and projected revenue of $15.04 billion. Analysts have revised their price targets, with Mizuho raising it to $300, Bernstein to $308, and TD Cowen to $325. Oracle shares rose 4.4% to $232.80. A $38 billion debt package is being prepared by JPMorgan and Mitsubishi UFJ to fund Oracle's data centers.
Oracle Corporation ORCL will release earnings results for the first quarter after the closing bell on Tuesday, Sept. 9.
Analysts expect the Austin, Texas-based company to report quarterly earnings at $1.48 per share, up from $1.39 per share in the year-ago period. Oracle projects to report quarterly revenue of $15.04 billion, compared to $13.31 billion a year earlier, according to data from Benzinga Pro.
Bloomberg, last week, reported that JPMorgan and Mitsubishi UFJ Financial Group are readying a $38 billion debt package to fund data centers connected to Oracle.
Oracle shares gained 4.4% to close at $232.80 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- Mizuho analyst Siti Panigrahi maintained an Outperform rating and raised the price target from $245 to $300 on Aug. 15, 2025. This analyst has an accuracy rate of 61%.
- Bernstein analyst Mark Moerdler maintained an Outperform rating and increased the price target from $269 to $308 on Aug. 6, 2025. This analyst has an accuracy rate of 67%.
- TD Cowen analyst Derrick Wood maintained a Buy rating and boosted the price target from $275 to $325 on Aug. 6, 2025. This analyst has an accuracy rate of 68%.
- B of A Securities analyst Brad Sills maintained a Neutral rating and increased the price target from $220 to $295 on Aug. 5, 2025. This analyst has an accuracy rate of 68%.
- UBS analyst Karl Keirstead maintained a Buy rating and raised the price target from $250 to $280 on July 17, 2025. This analyst has an accuracy rate of 76%.
Considering buying ORCL stock? Here’s what analysts think:
Read This Next:
- Top 2 Health Care Stocks That May Plunge This Month
Photo via Shutterstock
